Clinical Report: Vitamin D may ease cancer treatment skin toxicity
Overview
High-dose oral vitamin D demonstrated rapid improvement in skin toxicities associated with chemotherapy and radiation in a multicenter case series.
Background
Chemotherapy and radiation therapy often lead to significant skin toxicities, which can interrupt cancer treatment. This study explores the potential role of high-dose vitamin D as a supportive care measure in this context.
Data Highlights
| Outcome | Results |
|---|---|
| Patients reporting symptom relief | 26 of 30 (87%) |
| Clinician-assessed improvement | 23 of 30 (77%) |
| Median time to improvement | 5 days |
| Mean erythema score reduction | 4.36 to 2.21 |
| Patients continuing anticancer therapy | 24 of 33 (73%) |
Key Findings
- High-dose oral vitamin D (100,000 IU) was administered to 33 patients with chemotherapy- and radiation-associated skin toxicities.
- 87% of patients reported subjective symptom relief within 10 days.
- Clinician-assessed improvement in erythema was noted in 77% of patients.
- Mean erythema scores decreased significantly from baseline to day 10.
- No treatment-related adverse events or meaningful changes in serum calcium were observed.
Clinical Implications
Further research is warranted to establish the efficacy and optimal dosing of high-dose oral vitamin D for managing skin toxicities in cancer patients undergoing chemotherapy and radiation.
Conclusion
Further investigation in controlled trials is needed to assess the effects of high-dose oral vitamin D on skin toxicities related to cancer treatments.
Related Resources & Content
- Patil et al, JAMA Dermatology, 2026 -- High-Dose Oral Vitamin D for Toxic Effects of the Skin Associated With Chemotherapy and Radiation
- The ASCO Post, 2026 -- Case Series Supports High-Dose Oral Vitamin D for Cancer Therapy–Related Skin Toxicities
- ASCO Publications, 2019 -- Vitamin D deficiency in patients with newly diagnosed cancer.
- ASCO Publications — High-dose vitamin D supplementation for cancer-treatment-induced bone loss in 164 breast and prostate cancer patients: A pooled analysis of two randomized controlled trials (RCTs).
- the asco post — Vitamin D Supplements May Help Reduce Chemotherapy-Induced Peripheral Neuropathy
- MASCC oncodermatology clinical practice statement: prevention and management of acute radiation dermatitis with Mepitel Film and Hydrofilm
- High-Dose Oral Vitamin D for Toxic Effects of the Skin Associated With Chemotherapy and Radiation | Dermatology | JAMA Dermatology | JAMA Network
- Efficacy and safety of Mepitel film for radiodermatitis: a systematic review and meta-analysis - PMC
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
